New Zealand markets open in 2 hours 50 minutes

Entrada Therapeutics, Inc. (TRDA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
14.49+0.30 (+2.11%)
As of 02:55PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts4444
Avg. Estimate0.14-0.6-0.51-4.02
Low estimate-0.41-0.84-0.8-4.47
High estimate0.77-0.27-0.27-3.65
Year ago EPS-0.781.02-0.2-0.51
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts3433
Avg. Estimate36.43M20.53M136.07M51.14M
Low estimate25M13M134.1M48M
High estimate49.3M30M139.12M56.42M
Year ago sales9.78M9.6M129.01M136.07M
Sales growth (year/est)272.50%113.90%5.50%-62.40%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.69-0.74-0.17-0.59
Actual EPS-0.781.02-0.290.68
Difference-0.091.76-0.121.27
Surprise %-13.00%237.80%-70.60%215.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate0.14-0.6-0.51-4.02
7 days ago-0.16-0.59-1.28-3.58
30 days ago-0.58-0.67-2.5-3.47
60 days ago-0.73-0.78-2.49-3.47
90 days ago-0.72-0.77-2.45-3.38
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4341
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesTRDAIndustrySector(s)S&P 500
Current qtr.117.90%N/AN/AN/A
Next qtr.-158.80%N/AN/AN/A
Current year-155.00%N/AN/AN/A
Next year-688.20%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A